|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/451 | (2006.01) |
| A61P 21/00 | (2018.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 31/451 | (2013.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61P 21/00 | (2006.01) |
| (11) | Number of the document | 3512506 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17851614.2 |
| Date of filing the European patent application | 2017-09-15 | |
| (97) | Date of publication of the European application | 2019-07-24 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/051803 |
| Date | 2017-09-15 |
| (87) | Number | WO 2018/053280 |
| Date | 2018-03-22 |
| (30) | Number | Date | Country code |
| 201662395854 P | 2016-09-16 | US |
| (72) |
GEVA, Michal , IL
LAUFER, Ralph , IL
HAYDEN, Michael , IL
|
| (73) |
Prilenia Neurotherapeutics Ltd. ,
10 HaMenofim Street, Herzliya 4672561,
IL
|
| (54) | USE OF PRIDOPIDINE FOR TREATING RETT SYNDROME |
| USE OF PRIDOPIDINE FOR TREATING RETT SYNDROME |